2023 presents a golden opportunity for biomedical device manufacturers in California to sell their companies. With the biomedical device market booming and increasing demand for innovative solutions, there are numerous potential buyers ready to invest in quality products that solve market issues. It’s an exciting time for medical businesses as they prepare to strategize and compete for innovation supremacy. So, if you’re a biomedical device manufacturer with top-notch products, it’s time to make your move and seize the opportunity.
Biomedical Device Manufacturers by product type:
- Bio-sensor devices:
- Glucose monitoring
- Heart rhythm monitoring
- Blood pressure monitoring
- Oxygen level monitoring
- Bio-stimulator devices:
- Neurostimulation
- Muscular stimulation
- Brain stimulation
- Closed-loop delivery system applications:
- Used in bio-sensor and bio-stimulator applications
- Feedback from the subject is used to control the biomedical or other devices.
These biomedical devices are designed to improve the quality of life for patients and aid in the diagnosis and treatment of a variety of medical conditions. With advancements in technology and innovation, the possibilities for these devices are endless, and they continue to play a crucial role in the healthcare industry.
Such as
- Artificial organs
- Prosthetic devices
- Imaging equipment
- Diagnostic equipment
- Monitoring equipment
- Drug delivery systems
- Surgical instruments
- Dental equipment
- Cardiovascular devices
- Neurological devices
Overall, the biomedical device manufacturing industry is poised for continued growth and success as technology and healthcare continue to advance. By prioritizing innovation, quality control, regulatory compliance, and staying up to date with emerging trends and technologies, manufacturers can seize the opportunities presented by this dynamic industry.
US & California Biomedical Device Manufacturing Landscape
The total number of biomedical device manufacturing companies in the US is 1,000; California accounts for 21 percent of the total established operating biomedical device manufacturers in the US according to Vertical IQ.
A typical biomedical device manufacturer employs 105 workers and generates about $37 million annually.
- The biomedical device manufacturing industry consists of about 1,000 companies that employ 117,800 workers and generate nearly $39.7 billion annually.
- Capital expenditures, primarily on machinery and equipment, average 2% of annual revenue.
- About 21% of firms are located in California, followed by Minnesota (6%), Florida (6%), and Pennsylvania (6%).
- About 79% of establishments have less than 100 workers. The 50 largest firms generate about 77% of the industry’s revenue.
- About 51% of establishments are corporations, 32% are s-corporations, 14% are partnerships, and 3% are individual proprietors.
- The US imports $20 billion in biomedical device products in 2021, primarily from Mexico.
- The US exported $19.4 billion in biomedical device products in 2021, primarily to Netherlands, Mexico, and China.
- The global wireless biomedical devices market is forecasted to grow nearly 28% from $13 billion in 2019 to over $16.0 billion by 2027, according to Grand View Research.
- Artificial intelligence (AI) technology is being combined with bio-sensor-based devices to automate the delivery of treatments and to improve clinical outcomes by monitoring patient adherence to treatment protocols.
Source – Virtual IQ | NAICS: 339112 SIC: 3841
In California, as in the US, an increasing share of medical device manufacturers are owned by small and medium-sized companies accounting for 60 percent.
A recent study showed that the share of biomedical device manufacturers owned by:
- female entrepreneurs are 12%
- followed by 9.9% veteran owned
- and finally, 7% are owned by marginalized groups.
Forty percent are classified under a corporate entity.
Biomedical Device Manufacturers Growing M&A Opportunities
The biomedical device manufacturing industry is expected to continue being a lucrative M&A market in 2023, building on the momentum of the past year.
According to a report by PitchBook, healthcare saw the second-highest number of private equity deals in 2022, with a total deal value of $99 billion.
This indicates that investors are continuing to view healthcare as a reliable and profitable sector, and are willing to invest in it.
Additionally, with the increasing demand for medical devices, the biomedical device manufacturing industry is likely to continue to see growth in the coming years. This presents an opportunity for companies in the industry to take advantage of the strong market conditions and seek out potential buyers or investors.
With the right strategy and a focus on innovation, quality products, and efficient operations, biomedical device manufacturers can position themselves for a successful M&A deal in 2023.
“We are seeing things slow down relative to where we were coming off of an unprecedented level of deal activity in 2021,” PitchBook’s senior healthcare analyst Rebecca Springer told Fierce Healthcare.
Nevertheless, 2023 is poised to be an exhilarating year for the biomedical device manufacturing industry, as we witness a surge in M&A activity.
With industry consolidation and healthy cash reserves driving the market, now is the time to make a strategic move and position your company for success.
Don’t miss out on this opportunity to take your business to new heights and make a significant impact on the world of healthcare.
The future is bright, and the possibilities are endless.
California just closed 4 acquisitions in February & March 2023.
| Announced Date | Acquirer Name | Transaction Name | Price |
| Mar 6, 2023 | Bigfoot Biomedical | Bigfoot Biomedical was acquired by Insulet Corporation | $25M |
| Feb 14, 2023 | Novonate | Novonate acquired by Laborie Medical Technologies | — |
| Feb 9, 2023 | NuVasive | NuVasive acquired by Globus Medical | $3.1B |
Source: Crunchbase
As we delve into the world of biomedical device manufacturing, there are a few trends that stand out as crucial to understanding the industry’s current M&A landscape. These positive developments offer a roadmap for success, and we’ll explore each in detail to help you navigate the shifting tides.
As we continue to navigate the ever-evolving landscape of the biomedical device manufacturing industry, it’s important to take note of the crucial role that research and development play in driving progress and innovation.
In this competitive market, staying ahead of the curve is essential. Biomedical device manufacturers must constantly strive to improve their products, staying attuned to the latest trends and technologies to deliver cutting-edge solutions that meet the ever-changing needs of healthcare professionals and patients alike.
Investing in research and development not only fuels growth and innovation but also provides a competitive edge in a market where new and improved devices are constantly being developed. With advancements in technology and the growing demand for more effective and efficient medical solutions, there has never been a more important time to prioritize R&D efforts.
Additionally, the benefits of R&D extend beyond just product development. Investing in R&D can also result in cost savings by streamlining processes, improving manufacturing efficiency, and reducing waste. It can also lead to new partnerships and collaborations that can drive further growth and expansion.
EMR Integration
As healthcare technology advances, the integration of biomedical devices with electronic medical record systems (EMR) has become increasingly popular. This is no surprise, as the benefits are abundant. By simplifying workflows and enhancing the value of the EMR, clinicians can focus more on direct patient care, thereby improving patient outcomes and satisfaction. With the help of automated data entry, medical professionals can devote more time to their patients, rather than laboriously entering data. This not only leads to greater job satisfaction but also increases the accuracy and safety of patient care. It’s a win-win situation for all involved, and one that’s sure to become even more prevalent in the years to come.
Wireless Technology Demand
The future of healthcare monitoring is upon us, and it’s wireless! With the advent of low-power wearable and wireless sensors, continuous innovation in sensor, implant, and wireless communication is driving the rising demand for wireless medical technology applications. These devices offer medical practitioners the ability to remotely monitor patients in various settings, including hospitals, clinics, ambulances, and even at home. With some devices even allowing treatment to be provided remotely, the potential benefits of wireless biomedical devices are simply staggering. And with the added boost of increasing medical insurance reimbursement for these devices, it’s clear that the future of healthcare is truly wireless!
Neurostimulation Market Growth
The field of neurostimulation devices is experiencing a revolution, with new technological advancements expanding treatment options beyond the traditional uses for conditions like epilepsy, Parkinson’s disease, and depression. These devices are changing lives and pushing the boundaries of what was once thought impossible. With implanted devices and physical therapy, paraplegics are now able to walk again. With prosthetic hand systems incorporating wirelessly controlled neurostimulators, amputees can experience the sensation of touch. As if that weren’t enough, there are now neurostimulation systems in development that can target and stimulate neurons to treat metabolic or digestive diseases and alleviate pain without relying on medication. The possibilities are endless, and the future of neurostimulation is an exciting frontier for both patients and medical professionals alike.
In conclusion, the importance of research and development cannot be overstated in the biomedical device manufacturing industry. It’s not just about staying ahead of the competition, but about improving patient outcomes and driving progress in healthcare. With so much potential for growth and innovation, the future of this industry is bright for those who are willing to invest in R&D and push the boundaries of what is possible.
Quite frankly we’re living in an age where state-of-the-art healthcare access is no longer out of reach; aside from achieving better outcomes, it’s also translating into significant cost savings!
Rogerson Business Services have been brokering manufacturing companies since 2006 in California. We have sold many manufacturing-related businesses in various niches and sectors. Most recently, we sold a $36 million manufacturing company deal in 2021.
Send us an email to support@rogersonbusinessservices.com and get the full list of manufacturers sold.
Are you ready to unveil the hidden forces that shape this market? Let’s plunge into the depths and explore the factors that hold the power to make or break this environment.
5 M&A Biomedical Device Manufacturers Outlook in 2023
Interest Rates
Retiring Manufacturing Owners! Are you ready to secure your financial future?
The biomedical devices manufacturing industry is poised to be a hot investment prospect in 2023, and now is the time to act!
With higher interest rates and a recession-proof option, this sector offers a unique opportunity for strategic buyers and acquirers alike to experience strong returns on their investments.
As a California-based manufacturing business owner, selling now is the most opportune economic event, putting you in the driver’s seat of lucrative financial gain.
Don’t let this chance pass you by. Take action now and secure your financial future!
Strategic Buyers & Private Equity Investors
Welcome to California, where the biomedical device manufacturing industry is hotter than the summer sun!
From tongue depressors to sophisticated imaging systems, this market has it all – and you can bet that every prospective buyer and investor is salivating at the chance to get in on the action.
Who needs unlimited possibilities when you have surgical appliances, instruments & supplies, electro-medical equipment (pacemakers, etc.), diagnostic substances (lab-related goods), irradiation apparatus (X-Ray, etc.), dental products, and ophthalmic goods to choose from? It’s like a buffet for your investment portfolio!
And don’t forget about the trendy devices everyone’s talking about, like glucose monitoring, heart rhythm monitoring, blood pressure monitoring, oxygen level monitoring, neurostimulation, muscular stimulation, brain stimulation, and bio-sensor and bio-stimulator applications.
The feedback from the subject is used to control the biomedical or other devices – it’s like magic!
But wait, there’s more!
Say goodbye to reusable products and hello to single-use disposable medical instruments and devices. It’s a cost-effective solution that also reduces any risks associated with ineffective sterilization or potential contamination from reused equipment. Who needs sustainability when you can have convenience?
And let’s not forget about the boomer business owners who are passing the torch to a new generation of savvy investors. It’s like a never-ending cycle of greed and opportunism!
And why worry about recessions when the demand for medical devices remains strong and ever-expanding? It’s like the industry has a magic bubble protecting it from economic downturns.
So, if you’re ready to jump on the bandwagon and take advantage of this unprecedented chance, come on down to California and witness the medical device industry at the top of everyone’s bucket list!
Availability of Cash
As we look into the future, professionally managed biomedical device manufacturing companies remain highly desirable M&A targets.
The latest report on private equity investment shows that the industry is thriving with record-breaking levels of capital raised and deployed globally in 2022.
Private equity continues to be a popular choice for investors seeking high returns and diversification in their portfolios.
North America remains the dominant region for private equity activity, but emerging markets like Asia are quickly catching up. The report also highlights the growing interest in alternative assets such as real estate, infrastructure, and private debt, which are becoming increasingly popular among private equity investors. Private equity is a promising investment opportunity for those looking to secure their financial future and achieve significant returns on their investments according to Preqin.
With over $1 trillion in dry powder waiting to be invested, the industry is poised to continue its steady growth and generate substantial returns for those who can get in on the action.
So, if you’re looking for a surefire way to make a buck, just hand over your m&a sell-side process to a certified business broker in California and watch the magic happen!
Tax
Ah, Californians, are always one step ahead when it comes to navigating the complex world of taxes.
Even the Oracle of Omaha himself, Warren Buffet, can’t keep up!
But fear not, fellow taxpayers, this year brings a glimmer of hope as some tax relief allows you to continue building your investment portfolios without the looming threat of Biden’s proposed tax hikes in 2021/2022.
So let’s raise a glass to Californians and their uncanny ability to stay on top of the ever-changing tax landscape.
Timing
It’s time to bid adieu to this post on biomedical device manufacturing in California. Should you wait until 2028 to strike gold or take the plunge now?
Decisions, decisions! Retirement-age entrepreneurs, it’s time to put on your thinking caps and weigh the pros and cons. But wait, before you set sail, make sure to consult with a certified business broker who can help you navigate these choppy waters.
Rogerson Business Services has had a remarkable year in the buy-sell market, proving once again that anything is possible. 2022 is expected to be even better, but who knows what the future holds?
The only certainty is that 2023 is bound to be another year of excellence.
So, as we say goodbye to this post, remember to always plan, consult with experts, and keep an eye on the horizon. Who knows what treasures await?
Next: When Should I Sell My Company?
Now is the perfect storm to sell your business and retire from your biomedical manufacturer in California.
Hold onto your hats, folks! In a market that’s changing faster than the color of a chameleon, business owners in 2023 are eager to capitalize on every opportunity for profit.
And what better way to navigate these treacherous waters than with the help of a certified business broker in California?
With Rogerson Business Services’ expertise in determining values and creating attractive packages for buyers (all while keeping confidentiality under lock and key), Andrew Rogerson is the ultimate deal-making machine.
And let’s not forget about his amazing ability to form a reliable deal team – it’s like having the Avengers of the business world at your fingertips.
So go ahead, channel your inner Warren Buffet, and reach for the stars with the help of a certified business advisor. The sky’s the limit, baby!
Articles and Videos Worth Checking Out
1) 2023 Market Policy and Outlook
2) Baby Boomers Infrastructure & 2023 Outlook
4) Medical Device Manufacturers Association (MDMA)
5) Portable Biomedical Devices Market
Are You Ready To Sell Your Biomedical Device Manufacturing Company?
Rogerson Business Services (RBS) is a certified business brokerage firm specializing in selling manufacturing businesses in California. RBS created a comprehensive summary with every step of the selling process explaining the steps of the selling process, including what you can expect in establishing the proper price and valuation for your biomedical devices manufacturing business.
Get in touch today for a free consultation and let us learn a few things about your manufacturing business in California.
